Susie Annie Balfour, as Executrix of the Estate of Susie Annie Balfour, and Duwan Darnell Balfour, individually and on behalf of the wrongful death beneficiaries v. Jackson HMA, LLC, ET AL.

CourtDistrict Court, S.D. Mississippi
DecidedJune 4, 2026
Docket3:24-cv-00093
StatusUnknown

This text of Susie Annie Balfour, as Executrix of the Estate of Susie Annie Balfour, and Duwan Darnell Balfour, individually and on behalf of the wrongful death beneficiaries v. Jackson HMA, LLC, ET AL. (Susie Annie Balfour, as Executrix of the Estate of Susie Annie Balfour, and Duwan Darnell Balfour, individually and on behalf of the wrongful death beneficiaries v. Jackson HMA, LLC, ET AL.) is published on Counsel Stack Legal Research, covering District Court, S.D. Mississippi primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Susie Annie Balfour, as Executrix of the Estate of Susie Annie Balfour, and Duwan Darnell Balfour, individually and on behalf of the wrongful death beneficiaries v. Jackson HMA, LLC, ET AL., (S.D. Miss. 2026).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF MISSISSIPPI NORTHERN DIVISION

SUSIE ANNIE BALFOUR, as Executrix of the Estate of Susie Annie Balfour, and DUWAN DARNELL BALFOUR, individually and on behalf of the wrongful death beneficiaries PLAINTIFFS

v. CIVIL ACTION NO. 3:24-cv-93-KHJ-MTP

JACKSON HMA, LLC, ET AL. DEFENDANTS

ORDER

THIS MATTER is before the Court on the Motion to Strike [320] filed by Defendant Centurion of Mississippi, LLC (“Centurion”). In the Motion [320], Centurion requests that the Court strike Plaintiffs’ supplemental responses to Centurion’s first set of interrogatories and requests for production of documents. Having considered the parties’ submissions, the record, and the applicable law, the Court finds that the Motion to Strike [320] should be GRANTED in part and DENIED in part. BACKGROUND

The primary issue before the Court is whether to strike Plaintiffs’ disclosure of more than $1.7 million in alleged medical expenses claimed as part of their damages in this action, which arise from Susie Annie Balfour’s battle with breast cancer. Ms. Balfour was incarcerated with the Mississippi Department of Corrections for 33 years. See Complaint [1] at 8. Ms. Balfour claimed her cancer resulted from “clean[ing] the prison with chemicals known to cause, or to contribute to causing, breast and other cancers without any protective equipment.” Id. She also claimed that doctors, nurses, prison staff, and hospitals “failed to recognize or outright ignored the presence of suspicious masses, and failed to conduct, order or refer her for additional diagnostic examinations and/or procedures to confirm or deny presence of breast cancer.” Id. at 9. On February 14, 2024, Ms. Balfour filed this action against these doctors, nurses, prison staff, and hospitals. Ms. Balfour served her initial disclosures under Fed. R. Civ. P. 26(a)(1) on June 18, 2024, prior to the case management conference. See Notice [77]. As to her computation

of damages, which is required under Rule 26(a)(1)(iii), Ms. Balfour provided: Plaintiff is asserting claims for compensatory damages arising from or related to the present medical treatment she is currently receiving due to or as a result of Defendants’ negligence, all future medical treatment she will require due to or as a result of Defendants’ negligence, and loss of chance and/or diminished life expectancy. Plaintiff is also asserting claims for pain and suffering in an amount to be determined by a jury. Plaintiff is asserting a claim for punitive damages in an amount to be determined by a jury. Lastly, Plaintiff is asserting a claim for nominal damages in amount to be determined by a jury. As Plaintiff has not yet received all the bills, charges, and expenses related to the medical treatment she has received since her release from the custody of the Mississippi Department of Corrections, she will supplement her computation of damages during the course of discovery.

[320-1] at 4-5.

The Court entered a Case Management Order [91] on July 11, 2024, beginning the discovery period and setting the case deadlines and the trial of this matter. Centurion served its first set of interrogatories and requests for production of documents on September 5, 2024, requesting from Ms. Balfour, inter alia, a description of all damages and the production of all documents concerning damages. See [320-2] at 4-5, 8. However, on October 25, 2024, before Ms. Balfour responded to the discovery requests, the Court suspended the case deadlines and stayed discovery because Defendant Dr. Gloria Perry filed a Motion for Summary Judgment [109] raising qualified immunity as a defense. See Order [114]. On June 5, 2025, after dismissing Ms. Balfour’s claims against Dr. Perry, the Court lifted the stay of discovery and entered an Amended Scheduling Order [153]. Ms. Balfour responded to Centurion’s discovery requests on August 1, 2025. In response to Centurion’s interrogatory seeking a description of all damages, Ms. Balfour stated that she was seeking, among other things, “damages for her past, present, and future medical expenses,” but she did not identify any medical expenses or provide a computation of damages. See [320-3] at 7-8. Instead, she “reserved” the right to supplement her response. Id. at 8. In response to the

request for documents concerning damages, Ms. Balfour stated she “is requesting certified copies of her medical billing records from her providers and will supplement her response to this Request upon receipt of the same.” Id. at 28. Ms. Balfour died on August 1, 2025. See Suggestion of Death [171]. Then, on August 14, 2025, the Court suspended the case deadlines pending the filing and granting of a motion for substitution of party. See Order [179]. On November 6, 2025, after the parties were substituted,1 the Court entered an Order [189] resetting the trial of this matter and setting new case deadlines, including a January 15, 2026, deadline for Plaintiffs to designate experts, a February 16, 2026, deadline for Defendants

to designate experts, and an April 15, 2026, discovery deadline. On January 15, 2026, Plaintiffs designated four retained expert witnesses (Renee FallHowe, M.D., Carl Freter, M.D., Julie Miller, M.D. and Bill Brister, Ph.D) and 34 treating physicians as non-retained expert witnesses. See [320-4]. As for the retained expert witnesses’ reports, Dr. FallHowe’s concerns the medical care provided to Ms. Balfour, Dr Freter’s concerns disease progression and the timing of Ms. Balfour’s diagnosis, Dr. Miller’s concerns Ms.

1 Shirley Balfour, the executrix of the estate of Susie Balfour, was substituted as Plaintiff on November 6, 2025, and on February 12, 2026, Duwan Balfour, individually and on behalf of the wrongful death beneficiaries, was added as a Plaintiff. See Order [188]; Amended Complaint [260]. Balfour’s mammographic history, and Dr. Brister’s concerns the value of lost earnings and household services. See [320-5]. Concerning the treating physicians, Plaintiffs provided the following: Each named physician may testify regarding facts learned and opinion formed during the course of providing medical care and treatment to Ms. Balfour, including their diagnosis, treatment, or care of Ms. Balfour, as well as opinions regarding her condition, prognosis, and causation to the extend such opinions were formed with and as part of their treatment and care.

See [320-4] at 4.

On March 18, 2026, Plaintiffs moved for a 60-day extension of the discovery deadline. See Motion [278]. Finding that Plaintiffs had not provided good cause for the requested extension, the Court extended the discovery deadline by two weeks to April 29, 2026, and explained: “The parties should also note that this action has been pending for more than two years, and the Court desires that the case proceed expeditiously and expects the parties and counsel to proceed accordingly.” See Order [279]. The discovery deadline ran on April 29, 2026. The next day, Plaintiffs supplemented their response to Centurion’s interrogatory seeking a description of all damages with the following: Medical expenses incurred as a result of delayed diagnosis and treatment of metastatic breast cancer, including but not limited to diagnostic imaging, pathology and biopsy services, oncology consultations[,] systemic therapy and medications, hospitalizations, and palliative and hospice care in the amount of $1,749,166.67. The reasonableness and necessity of those medical expenses will be testified to [by] those persons identified in Plaintiff’s Rule 26(a)(2) Expert Witness Disclosures.

See [320-6] at 7.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Susie Annie Balfour, as Executrix of the Estate of Susie Annie Balfour, and Duwan Darnell Balfour, individually and on behalf of the wrongful death beneficiaries v. Jackson HMA, LLC, ET AL., Counsel Stack Legal Research, https://law.counselstack.com/opinion/susie-annie-balfour-as-executrix-of-the-estate-of-susie-annie-balfour-and-mssd-2026.